Evidence map›Paper›PMID 26451042›Full record

ArticleThe Journal of biological chemistry2015

Pseudomonas aeruginosa ExoT Induces Mitochondrial Apoptosis in Target Host Cells in a Manner That Depends on Its GTPase-activating Protein (GAP) Domain Activity.

Stephen J Wood, Josef W Goldufsky, Daniella Bello, Sara Masood, Sasha H Shafikhani

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Advances inMicroorganisms · 2025
    Review
  9. Article
  10. Infection and immunity · 2025
    Article
  11. Science translational medicine · 2025
    Article
  12. High prevalence of carbapenem-resistantFrontiers in microbiology · 2025
    Article
  13. Carbapenem-resistantFrontiers in pharmacology · 2025
    Article
  14. Review
  15. Article
  16. Mitochondrial Dysfunction in Bacterial Infections.Pathogens (Basel, Switzerland) · 2023
    Review
  17. Anti-Microorganisms · 2023
    Review
  18. Review
  19. Cells · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Stephen J WoodFrom the Department of Immunology/Microbiology.
Josef W GoldufskyFrom the Department of Immunology/Microbiology.
Daniella BelloFrom the Department of Immunology/Microbiology.
Sara MasoodFrom the Department of Immunology/Microbiology.
Sasha H ShafikhaniFrom the Department of Immunology/Microbiology, Department of Internal Medicine, and Cancer Center, Rush University Medical Center, Chicago, Illinois 60612 Sasha_Shafikhani@rush.edu.
Rush University Medical Center · US

Funding

Molecular dissection of Pseudomonas aeruginosa Exotoxin T virulence functionsR21AI110685 · NIAID · RUSH UNIVERSITY MEDICAL CENTER · PI SHAFIKHANI, SASHA H · 2015 to 2016
$426k
NIAID NIH HHS R21 AI110685NIAID NIH HHS R21 AI110685-01
6 · The paper itself

Abstract

Pseudomonas aeruginosa is the most common cause of hospital-acquired pneumonia and a killer of immunocompromised patients. We and others have demonstrated that the type III secretion system (T3SS) effector protein ExoT plays a pivotal role in facilitating P. aeruginosa pathogenesis. ExoT possesses an N-terminal GTPase-activating protein (GAP) domain and a C-terminal ADP-ribosyltransferase (ADPRT) domain. Because it targets multiple non-overlapping cellular targets, ExoT performs several distinct virulence functions for P. aeruginosa, including induction of apoptosis in a variety of target host cells. Both the ADPRT and the GAP domain activities contribute to ExoT-induced apoptosis. The ADPRT domain of ExoT induces atypical anoikis by transforming an innocuous cellular protein, Crk, into a cytotoxin, which interferes with integrin survival signaling. However, the mechanism underlying the GAP-induced apoptosis remains unknown. In this study, we demonstrate that the GAP domain activity is both necessary and sufficient to induce mitochondrial (intrinsic) apoptosis. We show that intoxication with GAP domain results in: (i) JNK1/2 activation; (ii) substantial increases in the mitochondrial levels of activated pro-apoptotic proteins Bax and Bid, and to a lesser extent Bim; (iii) loss of mitochondrial membrane potential and cytochrome c release; and (iv) activation of initiator caspase-9 and executioner caspase-3. Further, GAP-induced apoptosis is partially mediated by JNK1/2, but it is completely dependent on caspase-9 activity. Together, the ADPRT and the GAP domains make ExoT into a highly versatile and potent cytotoxin, capable of inducing multiple forms of apoptosis in target host cells.

Indexed as

ApoptosisADP Ribose TransferasesApoptosis Regulatory Proteinsbcl-2-Associated X ProteinBcl-2-Like Protein 11BH3 Interacting Domain Death Agonist ProteinCaspase 9Enzyme ActivationGTPase-Activating ProteinsHeLa CellsHumansMembrane ProteinsMitochondriaMitochondrial ProteinsMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase 9ADP Ribose TransferasesApoptosis Regulatory ProteinsBAX protein, humanbcl-2-Associated X ProteinBCL2L11 protein, humanBcl-2-Like Protein 11BH3 Interacting Domain Death Agonist ProteinBID protein, humanCASP9 protein, humanCaspase 9ExoT protein, Pseudomonas aeruginosaGTPase-Activating ProteinsMembrane ProteinsMitochondrial ProteinsMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase 9Proto-Oncogene Proteinsapoptosisbacterial toxinBaxBCL-2BidBimc-Junc-Jun N-terminal kinase (JNK)c-Jun transcription factorcytochrome cExoTJNKPseudomonas aeruginosa (P. aeruginosa)

Identifiers

PMID26451042
PMCPMC4661418
OpenAlexW2260270424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.